Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
25.80
+1.05 (4.24%)
Oct 20, 2025, 9:30 AM EDT - Market open
Intellia Therapeutics Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$28.84
Upside
+11.78%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold → Buy Upgrades $33 | Hold → Buy | Upgrades | $33 | +27.91% | Oct 6, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +16.28% | Sep 19, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $14 | Strong Buy | Maintains | $45 → $14 | -45.74% | Aug 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $68 → $60 | Strong Buy | Maintains | $68 → $60 | +132.56% | Aug 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $21 | Buy | Maintains | $25 → $21 | -18.60% | Aug 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $45 | Buy | Maintains | $50 → $45 | +74.42% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $25 | Strong Buy | Maintains | $30 → $25 | -3.10% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +16.28% | Jun 16, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $74 → $54 | Strong Buy | Maintains | $74 → $54 | +109.30% | Jun 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +16.28% | May 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +16.28% | May 20, 2025 |
| Wedbush | Wedbush | Hold Reiterates $10 | Hold | Reiterates | $10 | -61.24% | May 19, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $55 → $45 | Strong Buy | Maintains | $55 → $45 | +74.42% | May 12, 2025 |
| Citigroup | Citigroup | Hold Maintains $14 → $10 | Hold | Maintains | $14 → $10 | -61.24% | May 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $68 | Strong Buy | Maintains | $68 | +163.57% | May 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.